Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemia.
about
Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemia.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Overexpression of Tpl2 is link ...... l of chronic myeloid leukemia.
@en
Overexpression of Tpl2 is link ...... l of chronic myeloid leukemia.
@nl
type
label
Overexpression of Tpl2 is link ...... l of chronic myeloid leukemia.
@en
Overexpression of Tpl2 is link ...... l of chronic myeloid leukemia.
@nl
prefLabel
Overexpression of Tpl2 is link ...... l of chronic myeloid leukemia.
@en
Overexpression of Tpl2 is link ...... l of chronic myeloid leukemia.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Overexpression of Tpl2 is link ...... l of chronic myeloid leukemia.
@en
P2093
Alexander Tepper
Anna Chorzalska
John Morgan
Karim Roder
Peng Zhang
Steven Hines
Ting C Zhao
Xiaoqing Yu
P2860
P304
P356
10.1002/1878-0261.12186
P50
P577
2018-04-06T00:00:00Z